MCID: RHN004
MIFTS: 62

Rhinitis

Categories: Respiratory diseases, Smell/Taste diseases

Aliases & Classifications for Rhinitis

MalaCards integrated aliases for Rhinitis:

Name: Rhinitis 12 28 51 41 14 69
Runny Nose 12 3

Classifications:



External Ids:

Disease Ontology 12 DOID:4483
MeSH 41 D012220
NCIt 46 C34986
SNOMED-CT 64 70076002
UMLS 69 C0035455

Summaries for Rhinitis

CDC : 3 Sore throat and runny nose are usually the first signs of a cold, followed by coughing and sneezing. Most people recover in about 7-10 days. You can help reduce your risk of getting a cold: wash your hands often, avoid close contact with sick people, and don’t touch your face with unwashed hands.

MalaCards based summary : Rhinitis, also known as runny nose, is related to ige responsiveness, atopic and pollen allergy, and has symptoms including rhinorrhea, nasal irritation and sinus congestion. An important gene associated with Rhinitis is IL13 (Interleukin 13), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Allegra and Allegra-D have been mentioned in the context of this disorder. Affiliated tissues include testes, skin and eye, and related phenotypes are growth/size/body region and hematopoietic system

Disease Ontology : 12 A upper respiratory infectious disease which involves irritation and inflammation of the mucous membrane of the nose due to viruses, bacteria or irritants. The inflammation results in generation of excessive amounts of mucus leading to runny nose, as well as nasal congestion and post-nasal drip.

Wikipedia : 72 Rhinitis, also known as coryza, is irritation and inflammation of the mucous membrane inside the nose.... more...

Related Diseases for Rhinitis

Diseases in the Rhinitis family:

Chronic Rhinitis

Diseases related to Rhinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 259)
# Related Disease Score Top Affiliating Genes
1 ige responsiveness, atopic 32.8 IGHE IL13 IL4 IL4R IL5 RNASE3
2 pollen allergy 32.1 EPX ICAM1 IL13 IL4R IL5 RNASE3
3 giant papillary conjunctivitis 31.9 CCL11 CXCL8 IL4
4 common cold 31.6 CCL11 CCL5 CXCL8 ICAM1 IL13 IL5
5 allergic conjunctivitis 31.4 CCL11 CXCL8 HRH1 ICAM1 IL13 IL4
6 allergic rhinitis 31.1 CCL11 CXCL8 EPX FOXJ1 HRH1 ICAM1
7 sinusitis 30.8 CXCL8 CYSLTR1 IL4R IL5 RNASE3
8 pneumonia 30.6 CCL11 CCL5 CXCL8 IL13 IL5
9 dermatitis 30.5 CCL11 IGHE IL13 IL4 IL5 RNASE3
10 otitis media 30.4 CCL11 CXCL8 IGHE IL4 RNASE3
11 allergic bronchopulmonary aspergillosis 30.3 EPX IL4 IL5
12 intrinsic asthma 30.3 IL4 IL5 RNASE3
13 bronchitis 30.2 CCL11 CXCL8 IL5 RNASE3
14 food allergy 30.2 EPX IL13 IL4 IL5 RNASE3
15 blepharoconjunctivitis 30.1 CCL11 IL4 RNASE3
16 allergic hypersensitivity disease 30.1 CCL11 CCL5 EPX HRH1 IGHE IL13
17 vulvovaginitis 29.9 CCL11 CCL5 CXCL8
18 cough variant asthma 29.9 IL4 IL5 NGF RNASE3
19 conjunctivitis 29.9 CCL11 CXCL8 HRH1 ICAM1 IL13 IL4
20 chronic fatigue syndrome 29.8 CXCL8 NR3C1 POMC
21 lung disease 29.7 CCL5 CXCL8 IL13 IL5
22 allergic asthma 29.7 CCL11 CCL5 CXCL8 EPX IGHE IL13
23 vernal keratoconjunctivitis 29.1 CCL11 CCL5 ICAM1 IL13 IL4 IL5
24 keratoconjunctivitis 28.9 CCL11 CXCL8 ICAM1 IL13 IL4 IL5
25 dermatitis, atopic 28.6 CCL11 CCL5 CXCL8 EPX HRH1 ICAM1
26 asthma 27.6 CCL11 CCL5 CXCL8 CYSLTR1 EPX HRH1
27 chronic rhinitis 12.5
28 vasomotor rhinitis 12.5
29 atrophic rhinitis 12.4
30 asthma-related traits 4 11.8
31 olfactory neuroblastoma 11.3
32 actinobacillosis 11.2
33 asthma, nasal polyps, and aspirin intolerance 10.8
34 loeys-dietz syndrome 1 10.8
35 congenital syphilis 10.8
36 cytokine deficiency 10.6 IL13 IL5
37 loeffler endocarditis 10.6 IL5 RNASE3
38 paragonimiasis 10.6 IL13 IL5 RNASE3
39 angioimmunoblastic lymphadenopathy with dysproteinemia 10.6 IL13 IL5
40 pemphigoid gestationis 10.6 CCL11 IL5
41 eosinophilic granuloma 10.6 EPX RNASE3
42 nasopharyngitis 10.5
43 strongyloidiasis 10.5 CCL11 IL13 IL5
44 penicillin allergy 10.5 IL13 IL4 IL4R
45 beta-lactam allergy 10.5 IL13 IL4 IL4R
46 apple allergy 10.5 IL13 IL4 IL5
47 egg allergy 10.5 IGHE IL4 IL5
48 prurigo nodularis 10.5 NGF RNASE3
49 intestinal schistosomiasis 10.5 IL13 IL4 IL5
50 hyper ige syndrome 10.5 IGHE IL4 IL4R

Graphical network of the top 20 diseases related to Rhinitis:



Diseases related to Rhinitis

Symptoms & Phenotypes for Rhinitis

UMLS symptoms related to Rhinitis:


rhinorrhea, nasal irritation, sinus congestion, sneezing, posterior rhinorrhea, nasal congestion (finding)

MGI Mouse Phenotypes related to Rhinitis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 10.03 IL5 FOXJ1 KNG1 NGF HRH1 NR3C1
2 hematopoietic system MP:0005397 9.93 IL5 EPX HRH1 NR3C1 ICAM1 POMC
3 digestive/alimentary MP:0005381 9.87 IL4R IL5 FOXJ1 NR3C1 ICAM1 IL13
4 immune system MP:0005387 9.77 CYSLTR1 IL5 EPX HRH1 NR3C1 ICAM1
5 respiratory system MP:0005388 9.23 CYSLTR1 IL5 FOXJ1 NR3C1 IL13 IL4

Drugs & Therapeutics for Rhinitis

FDA approved drugs:

(show all 18)
# Drug Name Active Ingredient(s) 17 Company Approval Date
1
Allegra 17 FEXOFENADINE HYDROCHLORIDE Hoechst Marion Roussel July 1996
2
Allegra-D 17 FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE Hoechst Marion Roussel March 1998
3
Astelin nasal spray 17 AZELASTINE HYDROCHLORIDE Wallace Laboratories November 1996
4
Atrovent 17 IPRATROPIUM BROMIDE Boehringer Ingelheim January 1996
5
Clarinex 17 DESLORATADINE Schering-Plough February 2002
6
Clemastine fumarate syrup 17 CLEMASTINE FUMARATE Morton Grove Pharmaceuticals March 1998
7
Dymista 17 AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE Meda Pharmaceuticals Inc May 2012
8
Flonase Nasal Spray 17 FLUTICASONE PROPIONATE GlaxoSmithKline November 1997
9
Grastek 17 Timothy Grass Pollen Allergen Extract Merck April 2014
10
Nasacort AQ Nasal Spray 17 TRIAMCINOLONE ACETONIDE Phone-Poulenc Rorer October 1997
11
Oralair 17 Greer Labs April 2014
12
Patanase 17 OLOPATADINE HYDROCHLORIDE Alcon April 2008
13
Qnasl 17 BECLOMETHASONE DIPROPIONATE Teva Pharmaceutical March 2012
14
Ragwitek 17 Merck April 2014
15
Rhinocort Aqua Nasal Spray 17 BUDESONIDE AstraZeneca October 1999
16
Tri-Nasal Spray 17 Muro Pharmaceutical February 2000
17
Xyzal 17 LEVOCETIRIZINE DIHYDROCHLORIDE UCB May 2007
18
Zyrtec 17 CETIRIZINE HYDROCHLORIDE Pfizer December 1995

Drugs for Rhinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 419)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 51-45-6, 75614-87-8 774
2
Dexlansoprazole Approved, Investigational Phase 4,Phase 3 138530-94-6, 103577-45-3 9578005
3
Lansoprazole Approved, Investigational Phase 4,Phase 3 103577-45-3 3883
4
Capsaicin Approved Phase 4,Phase 2,Phase 1,Not Applicable 404-86-4 1548943
5
Cetirizine Approved Phase 4,Phase 3,Phase 2,Phase 1 83881-51-0 2678
6
Montelukast Approved Phase 4,Phase 3,Phase 2,Phase 1 158966-92-8 5281040
7
Nitric Oxide Approved Phase 4,Phase 1,Phase 2 10102-43-9 145068
8
Azelastine Approved Phase 4,Phase 3,Phase 2,Phase 1 58581-89-8 2267
9
Levocetirizine Approved Phase 4,Phase 3,Phase 2,Phase 1 130018-77-8
10
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 299-42-3 9294
11
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 83-43-2 6741
12
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-24-8 5755
13
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1 90-82-4 7028
14
Xylometazoline Approved, Investigational Phase 4 526-36-3 5709
15
Atropine Approved, Vet_approved Phase 4,Phase 2,Phase 1 5908-99-6, 51-55-8 174174
16
Diazepam Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 2 439-14-5 3016
17
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
18
Ketamine Approved, Vet_approved Phase 4,Phase 1 6740-88-1 3821
19
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
20
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
21
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2 26787-78-0 33613 2171
22
Desloratadine Approved, Investigational Phase 4,Phase 3,Phase 2 100643-71-8 124087
23
Loratadine Approved, Investigational Phase 4,Phase 3,Phase 2 79794-75-5 3957
24
Oxymetazoline Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 1491-59-4 4636
25
Phenylephrine Approved Phase 4,Phase 3,Phase 2,Phase 1 59-42-7 6041
26
Betamethasone Approved, Vet_approved Phase 4,Phase 3 378-44-9 9782
27
Omalizumab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 242138-07-4
28
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 93-14-1 3516
29
Acetaminophen Approved Phase 4,Phase 3 103-90-2 1983
30
Ciclesonide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 126544-47-6, 141845-82-1 444033
31
Fexofenadine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 83799-24-0 3348
32
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Not Applicable 124-94-7 31307
33
Adenosine Approved, Investigational Phase 4,Phase 2,Phase 1 58-61-7 60961
34
Budesonide Approved Phase 4,Phase 3,Phase 2 51333-22-3 5281004 63006
35
Doxazosin Approved Phase 4 74191-85-8 3157
36
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
37 Racepinephrine Approved Phase 4,Phase 3,Phase 2 329-65-7
38
Diphenhydramine Approved, Investigational Phase 4,Phase 3,Phase 1 58-73-1, 147-24-0 3100
39
Promethazine Approved, Investigational Phase 4,Phase 3,Phase 1 60-87-7 4927
40
Ethanol Approved Phase 4,Phase 2,Phase 1 64-17-5 702
41
Prazosin Approved Phase 4 19216-56-9 4893
42
Theophylline Approved Phase 4,Phase 2 58-55-9 2153
43
Tranilast Approved, Investigational Phase 4 53902-12-8 93543
44 Ebastine Approved, Investigational Phase 4 90729-43-4 3191
45
Ipratropium Approved Phase 4 22254-24-6, 60205-81-4 43232
46
Rizatriptan Approved Phase 4 144034-80-0, 145202-66-0 5078
47
Sumatriptan Approved, Investigational Phase 4 103628-46-2 5358
48
Dextromethorphan Approved Phase 4 125-71-3 5362449 5360696
49
Resveratrol Approved, Experimental, Investigational Phase 4,Phase 3 501-36-0 445154
50
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676

Interventional clinical trials:

(show top 50) (show all 1118)

# Name Status NCT ID Phase Drugs
1 Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis Unknown status NCT02014623 Phase 4 Control
2 Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais Unknown status NCT01115595 Phase 4
3 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate Unknown status NCT02278081 Phase 4 lansoprazole;placebo
4 Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites Unknown status NCT01052610 Phase 4 sublingual house dust mites allergen extract;placebo in sublingual applicator
5 Comparative Study of Sinol and Sinol-M in Patients With Congestion Due to Allergic Rhinitis Unknown status NCT00825656 Phase 4 Sinol or Sinol-M nasal spray
6 Elaboration of Patient-friendly Treatment Strategy With Capsaicin Nasal Spray in Patients With Idiopathic Rhinitis Unknown status NCT02288156 Phase 4 Capsaicin;placebo
7 Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis Unknown status NCT00488176 Phase 4 montelukast;cetirizine;montelukast and cetirizine;placebo
8 Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES) Unknown status NCT00406094 Phase 4 montelukast;placebo
9 AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR) Unknown status NCT02238353 Phase 4 azelastine + fluticasone;Placebo
10 Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination Therapy Unknown status NCT01062139 Phase 4 Xarlin (Levocetirizine);Cosalin (Petasites hybridus CO2 extract)
11 4"S" - Seasonal Symptoms Suppression Study Unknown status NCT02557269 Phase 4 Xylometazoline - intranasal application;Azelastine - intranasal application;Mometasone furoate - intranasal application;Hydroxyl-propyl-methyl cellulose powder - intranasal application;Bilastine 20 mg;Prednisolone 5 mg
12 POLlinosis and Exhaled Breath Temperature Unknown status NCT01785394 Phase 4 5 grass allergen extract
13 The Comparison of Different Administration Routes of Pediatric Premedication Unknown status NCT02313337 Phase 4 Anesthesia induction(midazolam,fentanyl,propofol,atracurium);Anesthesia maintenance(midazolam,fentanyl,propofol,atracurium)
14 Middle Meatal Bacteriology During Acute Respiratory Infection in Children Unknown status NCT00545961 Phase 4 placebo;amoxicillin clavulanate acid
15 Anti-inflammatory H1 Antihistamines Allergic Rhinitis Completed NCT02507635 Phase 4 Levocetirizine;Desloratadine
16 Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis Completed NCT01550471 Phase 4 Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo;Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase;QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo;QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris;Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase;Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris
17 Quality of Life in Patients With Allergic Rhinitis: Clinical Trial With Bilastine or Loratadine Completed NCT02513290 Phase 4 Bilastine;Loratadine
18 Comparison of Effectiveness and Safety of Sublingual Immunotherapy in Children With Allergic Rhinitis Completed NCT00698594 Phase 4
19 Effectiveness of Oxymetazoline Added on Nasal Steroid in Rhinitis With Persistent Nasal Obstruction Completed NCT01847131 Phase 4 oxymetazoline;Placebo nasal spray
20 Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis Completed NCT02551536 Phase 4 Montelukast;Fexofenadine;Levocetrizine
21 Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428) Completed NCT00963573 Phase 4 Loratadine;Betamethasone
22 Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270) Completed NCT00834119 Phase 4 Mometasone furoate;Mometasone furoate
23 Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms Completed NCT00460538 Phase 4
24 Efficacy and Tolerability of a Topical Microemulsion in Patients With Allergic Rhinitis Due to Sensitization to Pollen Completed NCT01478425 Phase 4
25 A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis Completed NCT00609674 Phase 4 Fluticasone furoate nasal spray;Placebo
26 Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial Completed NCT00691665 Phase 4 Olopatadine HCL Nasal Spray, 0.6%;Fluticasone Propionate Nasal Spray, 50 mcg
27 A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis Completed NCT01270958 Phase 4 Avamys aqueous nasal spray 110mcg
28 Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367) Completed NCT00442559 Phase 4 montelukast sodium;inhaled corticosteroid
29 Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis Completed NCT00355771 Phase 4 Levocetirizine;Placebo
30 Allergic Rhinitis Changes the Sinus Microbiome Completed NCT01852513 Phase 4 QNASL;Placebo nasal spray
31 Effectiveness of Individualized Homeopathic Treatment in Perennial Allergic Rhinitis Completed NCT00822406 Phase 4 homeopathic medicine;placebo
32 Comparison of the Effects of Nasal Steroids and Montelukast on Olfactory Functions in Patients With Allergic Rhinitis Completed NCT02565212 Phase 4 Montelukast,mometazon froat
33 Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR) Completed NCT00449072 Phase 4 TAA-AQ, Nasacort® AQ;Claritin®
34 To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis Completed NCT00679250 Phase 4 levocetirizine;placebo to levocetirizine
35 Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis Completed NCT02409563 Phase 4 Budesonide nasal spray (100 mcg bid);Budesonide nasal spray (50 mcg bid
36 A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis Completed NCT00682643 Phase 4 fluticasone furoate nasal spray;vehicle placebo nasal spray
37 Fluticasone and Salmeterol in Allergic Rhinitis Completed NCT01388595 Phase 4 FLUTICASONE PROPRIONATE;Salmeterol;PLACEBO
38 Alpha-Blockers in Allergic Rhinitis (MAN 01) Completed NCT01946035 Phase 4 Doxazosin XL
39 POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis) Completed NCT00160537 Phase 4 Levocetirizine
40 Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid o Completed NCT00806754 Phase 4 Ciclesonide nasal spray + placebo Azelastine;Ciclesonide nasal spray + Azelastine
41 Children, Perennial Allergic Rhinitis (PAR), l-t Growth Completed NCT00641212 Phase 4 Budesonide;Placebo
42 The Efficacy and Safety of Hyeonggaeyeongyo-tang for Chronic Rhinitis According to Pattern Identification in Korean Medicine Completed NCT02477293 Phase 4 Hyeonggaeyeongyo-tang
43 The Role of Montelukast in Rhinitis and Sleep Completed NCT00590772 Phase 4 montelukast;placebo
44 ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life) Completed NCT00160680 Phase 4 Levocetirizine
45 A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis Completed NCT00561717 Phase 4 Azelastine and placebo;Loratadine and Placebo;Cetirizine and Placebo;Placebo and Placebo (spray and Tablet)
46 A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712) Completed NCT01469234 Phase 4 loratadine;fexofenadine;placebo to loratadine;placebo to fexofenadine
47 Steroid Sparing Effect of Nasal Corticosteroid In Asthma And Rhinitis Completed NCT00903227 Phase 4 Fluticasone Evohaler pMDI;Placebo;Fluticasone Evohaler;Placebo intranasal spray;fluticasone propionate (Flixonase®)
48 A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis Completed NCT00653224 Phase 4 levocetirizine dihydrochloride;placebo
49 A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis Completed NCT00621959 Phase 4 levocetirizine dihydrochloride;placebo
50 Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006) Completed NCT02256553 Phase 4 Rescue Medication

Search NIH Clinical Center for Rhinitis

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: rhinitis

Genetic Tests for Rhinitis

Genetic tests related to Rhinitis:

# Genetic test Affiliating Genes
1 Rhinitis 28

Anatomical Context for Rhinitis

MalaCards organs/tissues related to Rhinitis:

38
Testes, Skin, Eye, T Cells, Pituitary, Lung, Neutrophil

Publications for Rhinitis

Articles related to Rhinitis:

(show top 50) (show all 2370)
# Title Authors Year
1
Cypress pollen allergy is responsible for two distinct phenotypes of allergic rhinitis different from other pollinosis. ( 29350019 )
2018
2
Smell loss is associated with severe and uncontrolled disease in children and adolescents with persistent allergic rhinitis. ( 29426750 )
2018
3
Allergic rhinitis management: what's next? ( 29406839 )
2018
4
Impact of acupuncture on antihistamine use in patients suffering seasonal allergic rhinitis: secondary analysis of results from a randomised controlled trial. ( 29440045 )
2018
5
Pattern of allergic rhinitis among children in Ekiti, Nigeria. ( 29447897 )
2018
6
Repeatability of nasal allergen challenge results - further validation of the allergic rhinitis clinical investigator collaborative (AR-CIC) protocols. ( 29432965 )
2018
7
Eating fish and farm life reduce allergic rhinitis at the age of twelve. ( 29446153 )
2018
8
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis. ( 29438602 )
2018
9
The use of specific immunoglobulin E in nasal secretions for the diagnosis of allergic rhinitis. ( 29417583 )
2018
10
Radiological comparison of inferior turbinate hypertrophy between allergic and non-allergic rhinitis: does allergy really augment turbinate hypertrophy? ( 29417277 )
2018
11
Correlation between upper and lower airway inflammations in patients with combined allergic rhinitis and asthma syndrome: A comparison of patients initially presenting with allergic rhinitis and those initially presenting with asthma. ( 29434763 )
2018
12
Otolaryngologist adherence to the AAO-HNSF Allergic Rhinitis Clinical Practice Guideline. ( 29412510 )
2018
13
Establishment of the Nasal Microbiota in the first 18 Months of Life - Correlation with Early Onset Rhinitis and Wheezing. ( 29452199 )
2018
14
Occupational allergic rhinitis and contact urticaria caused by Gum Arabic in a candy factory worker. ( 29446105 )
2018
15
The International Study of the Allergic Rhinitis Survey: outcomes from 4 geographical regions. ( 29423374 )
2018
16
The control of allergic rhinitis in real life: a multicenter cross-sectional Italian study. ( 29434524 )
2018
17
Changes in basophil activation during immunotherapy with house dust mite and mugwort in patients with allergic rhinitis. ( 29423373 )
2018
18
Benefits of Nasal Cellulose Powder Application Depend on the Type of Allergen Sensitization in Allergic Rhinitis. ( 29411560 )
2018
19
International consensus statement on allergy and rhinology: allergic rhinitis-executive summary. ( 29438600 )
2018
20
Associations of TAP1 genetic polymorphisms with atopic diseases: asthma, rhinitis and dermatitis. ( 29416713 )
2018
21
Dysbiosis of inferior turbinate microbiota is associated with high total IgE levels in allergic rhinitis patients. ( 29426044 )
2018
22
Reply to the letter to the author concerning: 'Does adenoid hypertrophy affect disease severity in children with allergic rhinitis?' ( 29423746 )
2018
23
Accuracy of serum-specific IgE test with microfluidic array enzyme-linked immunosorbent assay for diagnosing inhalant allergen sensitization in asthma and/or rhinitis allergy patients in Jakarta, Indonesia. ( 29423377 )
2018
24
Basophils from allergic rhinitis patients show allergen-specific upregulation of thymic stromal lymphopoietin receptor. ( 29413340 )
2018
25
The significance of the levels of IL-4, IL-31 and TLSP in patients with asthma and/or rhinitis. ( 28303765 )
2017
26
Food allergy and allergic rhinitis in 435 asian patients - A descriptive review. ( 28889132 )
2017
27
Allergen immunotherapy in allergic rhinitis: Current use and future trends. ( 28532268 )
2017
28
Histamine H4 receptor gene polymorphisms: a potential predictor of oral H1 antihistamine efficacy for allergic rhinitis. ( 27888642 )
2017
29
A functional variant of miRNA-149 confers risk for allergic rhinitis and comorbid asthma in Chinese children. ( 28181414 )
2017
30
Non-Allergic Rhinitis: Position paper of the European Academy of Allergology and Clinical Immunology. ( 28474799 )
2017
31
Therapeutic potential of I+-lipoic acid derivative, sodium zinc histidine dithiooctanamide, in a mouse model of allergic rhinitis. ( 28863235 )
2017
32
Recurrent CSF Rhinorrhea Misdiagnosed as Chronic Allergic Rhinitis with Subsequent Development of Bacterial Meningitis. ( 28819362 )
2017
33
Adenoid hypertrophy in children and allergic rhinitis. ( 28887688 )
2017
34
Effects of anticholinergic agent on miRNA profiles and transcriptomes in a murine model of allergic rhinitis. ( 28901404 )
2017
35
Hydrogen-Rich Saline Ameliorates Allergic Rhinitis by Reversing the Imbalance of Th1/Th2 and Up-Regulation of CD4+CD25+Foxp3+Regulatory T Cells, Interleukin-10, and Membrane-Bound Transforming Growth Factor-I^ in Guinea Pigs. ( 28894978 )
2017
36
Role of Interleukin-17A on the Chemotactic Responses to CCL7 in a Murine Allergic Rhinitis Model. ( 28046055 )
2017
37
Kinetic oscillatory stimulation of nasal mucosa in non-allergic rhinitis: comparison of patient self-administration and caregiver administration regarding pain and treatment effect. A randomized clinical trial. ( 28498078 )
2017
38
Effect of nasal allergen challenge in allergic rhinitis on mitochondrial function of peripheral blood mononuclear cells. ( 28073613 )
2017
39
Comorbidities of Atopic Dermatitis: Beyond Rhinitis and Asthma. ( 28890845 )
2017
40
Could Sublingual Immunotherapy Affect Oral Health in Children with Asthma and/or Allergic Rhinitis Sensitized to House Dust Mite. ( 28950285 )
2017
41
Basophil activation test for inhalant allergens in pediatric patients with allergic rhinitis. ( 28483235 )
2017
42
Role of Histopathology in Differentiating Primary Atrophic Rhinitis from Atrophic Stage of Rhinoscleroma. ( 28239581 )
2017
43
An intronic single-nucleotide polymorphism (rs13217795) in FOXO3 is associated with asthma and allergic rhinitis: a case-case-control study. ( 29141605 )
2017
44
Management of allergic rhinitis in the era of effective over-the-counter treatments. ( 28532204 )
2017
45
Mouse Model of IL-17-Dominant Rhinitis Using Polyinosinic-Polycytidylic Acid. ( 28913994 )
2017
46
Associations of single nucleotide polymorphisms of PTPN22 and Ctla4 genes with the risk of allergic rhinitis in a Chinese Han population. ( 27888068 )
2017
47
The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study. ( 28906011 )
2017
48
PHENOTYPE OF ALLERGIC RHINITIS AND RHINOSINUSITIS. ( 28515393 )
2017
49
"Allergic mood" - Depressive and anxiety symptoms in patients with seasonal allergic rhinitis (SAR) and their association to inflammatory, endocrine, and allergic markers. ( 28495610 )
2017
50
Mesenchymal stromal cells ameliorate acute allergic rhinitis in rats. ( 28940415 )
2017